Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peptide Protein Research Ltd (PPR Ltd) is a UK-based contract research organization specializing in the custom synthesis of synthetic peptides and peptide-based molecules. Established in 1999, the company provides a wide range of services including the synthesis of difficult and hydrophobic sequences, peptide modifications such as biotinylation and fluorescent labeling, and the production of peptidomimetics. Operating through its service brand, PeptideSynthetics, PPR caters to academic, pharmaceutical, and biotechnology clients globally. The company is recognized for its expertise in complex peptide chemistry and conducts all synthesis in-house at its facilities in Hampshire, UK. In addition to its commercial services, PPR maintains an active research interest in developing new synthetic methods and collaborates with academic institutions like the University of Surrey.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peptide Protein Research.